David A. Esposito
President and CEO
David is responsible for leading the management team in the accomplishment of key company objectives. He has extensive experience in sales, marketing, and commercial strategy. He was President of Phadia US Inc. (allergy and autoimmune diagnostics) and played a pivotal role in the sale of the business to Thermo Fisher Scientific for $3.5B USD in 2011. David began his career with Merck & Co. Inc., as a sales representative and worked through various senior management positions. He led commercial strategy for the US Division and played a key role in Merck’s efforts to develop a New Commercial Model in the pharmaceutical industry. He is on the Board of Medizone International (MZEI), an early-stage company commercializing a novel disinfectant technology for health-care facilities. David is a combat veteran. He led an infantry platoon with the 101st Airborne Division through several combat operations and was recognized with a Bronze Star for combat action in Iraq in 1991. David has a B.S. from the United States Military Academy at West Point and a MBA from Syracuse University.